Gala Pharmaceutical Inc. Retained Earnings
Gala Pharmaceutical Inc. had Retained Earnings of -$7.77 million as of 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-07-23
- 2019-05-31: Retained Earnings (Accumulated Deficit) -$7.77M.
- 2019-02-28: Retained Earnings (Accumulated Deficit) -$5.65M.
- 2018-11-30: Retained Earnings (Accumulated Deficit) -$5.08M.
- 2018-08-31: Retained Earnings (Accumulated Deficit) -$4.91M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2019-05-31 | -$7.77M 10-Q · filed 2019-07-23 |
| 2019-02-28 | -$5.65M 10-Q · filed 2019-04-30 |
| 2018-11-30 | -$5.08M 10-Q · filed 2019-07-23 |
| 2018-08-31 | -$4.91M 10-Q · filed 2018-10-26 |
| 2018-05-31 | -$4.20M 10-Q · filed 2018-08-01 |
| 2018-02-28 | -$3.80M 10-Q · filed 2018-05-08 |
| 2017-11-30 | -$3.22M 10-K · filed 2019-04-15 |
| 2017-08-31 | -$2.34M 10-Q · filed 2017-10-19 |
| 2017-05-31 | -$1.64M 10-Q · filed 2017-07-28 |
| 2017-02-28 | -$1.27M 10-Q · filed 2017-04-18 |
| 2016-11-30 | -$1.24M 10-K · filed 2018-04-06 |
| 2016-08-31 | -$1.21M 10-Q · filed 2016-11-04 |
| 2016-05-31 | -$1.16M 10-Q · filed 2016-07-15 |
| 2016-02-29 | -$1.11M 10-Q · filed 2016-05-10 |
| 2015-11-30 | -$1.07M 10-K/A · filed 2017-03-23 |
| 2015-08-31 | -$950.81K 10-Q · filed 2015-10-20 |
| 2015-05-31 | -$743.13K 10-Q · filed 2015-07-30 |
| 2015-02-28 | -$646.78K 10-Q · filed 2015-04-22 |
| 2014-11-30 | -$387.07K 10-K · filed 2016-03-22 |
| 2013-11-30 | -$108.20K 10-K · filed 2015-03-13 |